Purmorphamine

Purmorphamine was the first small-molecule agonist developed for the protein Smoothened, a key part of the hedgehog signaling pathway, which is involved in bone growth, cardiovascular regeneration and brain development as well as having a…

Uses your system voice; voice and rate in settings.

≈ 2 min read

Cite, export and learn8 citation formats · 8 exports · lesson and quiz

Names in other languages

No names in other languages are held for this entry yet.

Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.

Purmorphamine was the first small-molecule agonist developed for the protein Smoothened, a key part of the hedgehog signaling pathway, which is involved in bone growth, cardiovascular regeneration and brain development as well as having a number of other functions in the body. Purmorphamine has been shown to induce osteogenesis in bone tissue as well as influencing growth and differentiation of neurons in the brain.[1][2][3][4][5][6] [7]

References

edit edit source
  1. ^ Wu X, Ding S, Ding Q, Gray NS, Schultz PG (December 2002). "A small molecule with osteogenesis-inducing activity in multipotent mesenchymal progenitor cells". Journal of the American Chemical Society. 124 (49): 14520–1. doi:10.1021/ja0283908. PMID 12465946. Wikipedia revision 1330457969, retrieved 2026-11-19
  2. ^ Wu X, Walker J, Zhang J, Ding S, Schultz PG (September 2004). "Purmorphamine induces osteogenesis by activation of the hedgehog signaling pathway". Chemistry & Biology. 11 (9): 1229–38. doi:10.1016/j.chembiol.2004.06.010. PMID 15380183. Wikipedia revision 1330457969, retrieved 2026-11-19
  3. ^ Sinha S, Chen JK (January 2006). "Purmorphamine activates the Hedgehog pathway by targeting Smoothened". Nature Chemical Biology. 2 (1): 29–30. doi:10.1038/nchembio753. PMID 16408088. S2CID 29035911. Wikipedia revision 1330457969, retrieved 2026-11-19
  4. ^ Lee SJ, Lee HK, Cho SY, Choi JK, Shin HK, Kwak EJ, et al. (October 2008). "Identification of osteogenic purmorphamine derivatives". Molecules and Cells. 26 (4): 380–6. PMID 18695357. Wikipedia revision 1330457969, retrieved 2026-11-19
  5. ^ Stanton BZ, Peng LF (January 2010). "Small-molecule modulators of the Sonic Hedgehog signaling pathway". Molecular BioSystems. 6 (1): 44–54. doi:10.1039/b910196a. PMID 20024066. Wikipedia revision 1330457969, retrieved 2026-11-19
  6. ^ Aravamudhan A, Ramos DM, Nip J, Subramanian A, James R, Harmon MD, et al. (2013). "Osteoinductive small molecules: growth factor alternatives for bone tissue engineering". Current Pharmaceutical Design. 19 (19): 3420–8. doi:10.2174/1381612811319190008. PMID 23432678. Wikipedia revision 1330457969, retrieved 2026-11-19
  7. ^ Sharma S, Kaur A, Sharma S (April 2018). "Preconditioning potential of purmorphamine: a hedgehog activator against ischaemic reperfusion injury in ovariectomised rat heart". Perfusion. 33 (3): 209–218. doi:10.1177/0267659117732401. PMID 29065787. S2CID 3978923. Wikipedia revision 1330457969, retrieved 2026-11-19

Text derived from https://en.wikipedia.org/w/index.php?oldid=1330457969 under CC BY-SA 4.0; modifications have been made.

Provenance

snapshot enwiki-001330457969 · captured 2025-12-31 · ledger · version history

Cite this page as: encyclopegia.org, “Purmorphamine”, snapshot enwiki-001330457969. https://encyclopegia.org/a/purmorphamine